HomeCMPX • NASDAQ
add
Compass Therapeutics Inc.
Previous close
$0.86
Day range
$0.83 - $0.89
Year range
$0.77 - $3.04
Market cap
122.87M USD
Avg Volume
406.92K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 12.77M | 31.50% |
Net income | -10.79M | -37.64% |
Net profit margin | — | — |
Earnings per share | -0.08 | -33.33% |
EBITDA | -12.62M | -32.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 156.26M | -10.80% |
Total assets | 161.14M | -14.27% |
Total liabilities | 4.08M | -67.88% |
Total equity | 157.06M | — |
Shares outstanding | 137.59M | — |
Price to book | 0.75 | — |
Return on assets | -20.08% | — |
Return on capital | -20.68% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -10.79M | -37.64% |
Cash from operations | -13.89M | -13.57% |
Cash from investing | -4.10M | -196.02% |
Cash from financing | 17.43M | 42,419.51% |
Net change in cash | -554.00K | 93.00% |
Free cash flow | -10.39M | -8.47% |
About
Founded
2014
Headquarters
Website
Employees
32